UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM‐associated syndromes

American journal of medical genetics. Part A, 2023-07, Vol.191 (7), p.1826-1835

2023

Volltextzugriff (PDF)

Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease

The Lancet. Haematology, 2024-08, Vol.11 (8), p.e556-e559

2024

Volltextzugriff (PDF)

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Blood advances, 2019-07, Vol.3 (14), p.2057-2068

2019

Volltextzugriff (PDF)

Global perspectives on cellular therapy for children with sickle cell disease

Current opinion in hematology, 2022-11, Vol.29 (6), p.275-280

2022

Volltextzugriff (PDF)

Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2797-2803

2021

Volltextzugriff (PDF)

Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee

Cytotherapy (Oxford, England), 2024-07, Vol.26 (7), p.660-671

2024

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab

Pediatric hematology and oncology, 2024-05, Vol.41 (4), p.260-272

2024

Volltextzugriff (PDF)

Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma

Bone marrow transplantation (Basingstoke), 2022-04, Vol.57 (4), p.579-585

2022

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma

Pediatric transplantation, 2018-08, Vol.22 (5), p.e13210-n/a

2018

Volltextzugriff (PDF)

Cognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?

Journal of adolescent and young adult oncology, 2016-09, Vol.5 (3), p.226-231

2016

Volltextzugriff (PDF)

Red Cell Rheology and Blood Viscosity in Pediatric Individuals Having Received Allogenic Hematopoietic Stem Cell Transplantation or Ex Vivo Autologous Gene Therapy for Sickle Cell Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.1076-1076

2023

Volltextzugriff (PDF)

Targeting of CD25+ Activated T Cells in Gvhd-Associated Marrow Suppression and Cytopenias

Blood, 2023-11, Vol.142 (Supplement 1), p.7033-7033

2023

Volltextzugriff (PDF)

Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant

Blood, 2019-11, Vol.134 (Supplement_1), p.996-996

2019

Volltextzugriff (PDF)

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Blood, 2023-11, Vol.142 (Supplement 1), p.4955-4955

2023

Volltextzugriff (PDF)

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Blood, 2021-11, Vol.138 (Supplement 1), p.3030-3030

2021

Volltextzugriff (PDF)

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era

Blood, 2019-11, Vol.134 (Supplement_1), p.2056-2056

2019

Volltextzugriff (PDF)

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment

Blood, 2018-11, Vol.132 (Supplement 1), p.2086-2086

2018

Volltextzugriff (PDF)

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Blood, 2018-11, Vol.132 (Supplement 1), p.2260-2260

2018

Volltextzugriff (PDF)

Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders

Blood, 2019-11, Vol.134 (Supplement_1), p.83-83

2019

Volltextzugriff (PDF)

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S226-S227

2015

Volltextzugriff (PDF)

Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population

The American journal of cardiology, 2010-10, Vol.106 (7), p.963-968

2010

Volltextzugriff (PDF)

Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells

Nature communications, 2021-06, Vol.12 (1), p.3862-16, Article 3862

2021

Volltextzugriff (PDF)

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score

Heart rhythm, 2013-09, Vol.10 (9), p.1272-1277

2013

Volltextzugriff (PDF)

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

Heart rhythm, 2010-04, Vol.7 (4), p.433-437

2010

Volltextzugriff (PDF)

1 – 25 von 260

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Expanded phenotypic and hematologic abnormalities beyond bone marrow failure in MECOM‐associated syndromes

Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Global perspectives on cellular therapy for children with sickle cell disease

Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience

Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee

Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab

Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma

Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma

Cognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?

Red Cell Rheology and Blood Viscosity in Pediatric Individuals Having Received Allogenic Hematopoietic Stem Cell Transplantation or Ex Vivo Autologous Gene Therapy for Sickle Cell Disease

Targeting of CD25+ Activated T Cells in Gvhd-Associated Marrow Suppression and Cytopenias

Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population

Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

Suchergebnisse filtern